Use Of Arvs In Patients With Cryptococcal
Patients initiating ART with undiagnosed cryptococcal disease are at higher risk of early mortality than patients who are pre-emptively diagnosed and treated for cryptococcal disease. All patients initiating ART should be clinically screened for evidence of symptomatic cryptococcal disease — headache, neck stiffness, fever, focal neurologic signs, confusion, and altered mental status. All those who screen positive should be referred for further diagnostic work up for meningitis. Screening of asy
Chapter 9: Antiretroviral TherapyTreatments
1 drugOther
Preg. Unknown
Indication: Use Of Arvs In Patients With Cryptococcal
Adult Dose
200mg
Route
oral
Frequency
daily
Duration
6 months